Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Ron Flanigan who wrote (3705)	6/24/1998 11:33:00 AM
From: DT	Read Replies (1) \| Respond to of 9523

Ron, You make an interesting point RE class action lawsuits and consumer demand for Viagra. Within the pharmacy benefits community, a major consideration regarding Viagra cover/don't cover decisions focuses on existing coverage of other ED products. The HMO executives making the decision to exclude Viagra are aware that by continuing to cover other ED products they are in an extremely vulnerable legal position. The natural conclusion (IMHO) is that either limited Viagra coverage under certain guidelines will be adopted by most plans or all ED products will be carved out of regular pharmacy benefit plans and offered as an additional rider. By the way, can anyone tell me the earnings announcement date? DT

To: Ron Flanigan who wrote (3705)	6/24/1998 12:51:00 PM
From: Anthony Wong	Respond to of 9523

This piece of news is bizarre: Viagra reaches Lebanon, terrorizes wife dailynews.yahoo.com P.S. Ron, if I remember correctly, there are already several class action suits filed against HMOs (on their refusal to cover Viagra). I think I read somewhere that Kaiser (or Aetna) would cover the evaluation of impotence but not the drug.